Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical Checklist

Abstract

The quality of life for a patient has been transformed in the last 15 years due to innovations that have resulted in better treatments for severe psoriasis, a chronic inflammatory cutaneous disease. Now, novel therapies for psoriasis need to reach a high standard in order to offer patients with psoriasis a genuine alternative. Here we outline a suggested critical checklist that will help industry sponsors, researchers, and clinicians evaluate novel therapeutics for psoriasis.

Inflammation: Treatment Progress and Limitations

“…The challenges that have to be taken into account, like optimally designing such clinical trials in chronic inflammatory diseases, are nicely illustrated in the review by Yiu and Warren, which focuses on psoriasis therapeutics . The authors suggest a “critical checklist” that could be considered in the evaluation of novel therapeutic developments.…”